Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Purpose
The participants are being asked to take part in this clinical trial, a type of research study, because the participants are scheduled to receive or have recently received a hematopoietic cell transplant (HCT) or a solid organ transplant (SOT). Primary Objective To determine if pre-transplant screening for respiratory viral load predicts RVI within 1- year post-transplant among survivors. Secondary Objectives: - To develop and validate a classifier based on pre-transplant immunological profile predictive of developing an acute respiratory viral infection (aRVI), with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors. - To develop and validate a classifier based on Day +100 post-transplant immunological profiles predictive of developing an acute respiratory viral infection (aRVI),with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors .
Conditions
- Hematopoietic Cell Transplant
- Solid Organ Transplant
- Respiratory Viral Infection
Eligibility
- Eligible Ages
- Under 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Less than 18 years at the time of anticipated transplant - Participant meets one of the following criteria: 1. scheduled to receive allogeneic hematopoietic cell transplant within 14 days of enrollment or 2. Scheduled to or received solid organ transplant within 7 days before or after enrollment - Participant is receiving care at the time of enrollment at one of the study participating institutions. - Parent/guardian willing and able to provide informed consent, and if appropriate, child willing and able to provide informed assent. Donor Inclusion Criteria - Donor for HCT recipient enrolled on the VIPER study. - Willing and able to provide informed consent.
Exclusion Criteria
Recipient Exclusion Criteria None Donor Exclusion Criteria - Is not an HCT donor for a participant enrolled on the VIPER study. - Not available to provide pre-transplant research blood sample.
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Hematopoietic Cell Transplantation (HCT) | Early and accurate diagnosis of respiratory viral infections (RVIs) in children and adolescents who have undergone HCT is important for improving outcomes. The investigators are doing this study to understand more about how RVIs affect children who receive a transplant. | |
| Solid Organ Transplant (SOT) | Early and accurate diagnosis of respiratory viral infections (RVIs) in children and adolescents who have undergone SOT is important for improving outcomes. The investigators are doing this study to understand more about how RVIs affect children who receive a transplant. |
Recruiting Locations
Birmingham, Alabama 35294
Little Rock, Arkansas 72202
Washington D.C., District of Columbia 20010
Atlanta, Georgia 30322
Chicago, Illinois 60637
Louisville, Kentucky 40202
Victoria Statler, MD
Boston, Massachusetts 02115
Ann Arbor, Michigan 48109
Detroit, Michigan 48201
Minneapolis, Minnesota 55455
Omaha, Nebraska 68198
The Bronx, New York 10467
Cincinnati, Ohio 45229
Columbus, Ohio 43205
Masako Shimamura, MD
614-722-4452
Charleston, South Carolina 29425
Memphis, Tennessee 38103
Memphis, Tennessee 38105
Memphis, Tennessee 38105
Fort Worth, Texas 76104
marysuzanne.whitworth@cookchildrens.org S. Whitworth, MD
682-885-1485
marysuzanne.whitworth@cookchildrens.org
Houston, Texas 77030
Houston, Texas 77030
Houston, Texas 77225-0036
Seattle, Washington 98105
Milwaukee, Wisconsin 53226
More Details
- Status
- Recruiting
- Sponsor
- Arkansas Children's Hospital Research Institute
Detailed Description
The investigators will collect a nasal swab and blood sample from the participant when the participant is enrolled on the study and if the participant develops a RVI in the first year after transplant. The investigators will collect a blood sample 100 days after the participant's transplant.